Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Burkitt Lymphoma 20Multiple Myeloma 16Lymphoma, Large B-Cell, Diffuse 15Leukemia, Myeloid, Acute 14Lymphoma, Non-Hodgkin 13Lymphoma, Follicular 13Lymphoma, B-Cell 12Lymphoma 12Recurrence 10Myelodysplastic Syndromes 10Leukemia, Lymphocytic, Chronic, B-Cell 10Ovarian Neoplasms 9Hematologic Neoplasms 9Lymphoma, Mantle-Cell 8Hodgkin Disease 8Pancreatic Neoplasms 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Leukemia 7Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 6Leukemia, Myelomonocytic, Chronic 6Breast Neoplasms 6Neoplasms 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Biphenotypic, Acute 5Triple Negative Breast Neoplasms 4Stomach Neoplasms 4Sarcoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Osteosarcoma 4

Interventions

Paclitaxel 3Oxaliplatin 3Leucovorin 3Fluorouracil 3Docetaxel 3Capecitabine 3zolbetuximab 2trastuzumab deruxtecan 2pembrolizumab 2enzalutamide 2darolutamide 2Ramucirumab 2Nivolumab 2Irinotecan 2trifluridine tipiracil drug combination 1repotrectinib 1regorafenib 1lenvatinib 1ipatasertib 1fludarabine 1durvalumab 1atezolizumab 1apalutamide 1aldesleukin 1abiraterone 1X-Rays 1Vinorelbine 1Trifluridine 1Radiosurgery 1Radiation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Adenocarcinoma × Cyclophosphamide × 30 days × Clear all
NCT02133196 2026-06-05

T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer

National Institutes of Health Clinical Center (CC)

Phase 2 Recruiting
85 enrolled
Thoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Neoplasm Metastasis, Carcinoma, Adenosquamous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡